Pancreatic Cancer Research

ResearcherChongqing UniversityActive in the last 2 years

Jianyou Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7778-2539; OpenAlex author ID A5103060738. Sources: OpenAlex.

Their work

Papers
14 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2019: 2 papers · 2020: 4 papers · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 3 papers

Papers 14

  1. A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer. First author DOI 10.1016/j.bioactmat.2025.12.039↗
  2. Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreati… Co-author DOI 10.1016/j.drup.2026.101404↗
  3. SLC6A14-mediated carnitine transmembrane uptake from PPARγ+ cancer-associated fibroblasts promotes recurrence of pancreatic cancer. First author DOI 10.1136/gutjnl-2025-336116↗
  4. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance. Co-author DOI 10.1016/j.drup.2023.101027↗
  5. Identifying suitable candidates for pancreaticoduodenectomy with extended lymphadenectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2024.07.405↗
  6. GAP-43 targeted indocyanine green-loaded near-infrared fluorescent probe for real-time mapping of perineural invasion lesions in pancreatic cancer in vivo. Co-author DOI 10.1016/j.nano.2023.102671↗
  7. Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by act… Co-author DOI 10.1186/s12935-022-02835-0↗
  8. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1186/s12943-022-01587-9↗
  9. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. Co-author DOI 10.1038/s41419-020-2617-7↗
  10. Establishing and validating a pathway prognostic signature in pancreatic cancer based on miRNA and mRNA sets using GSVA. First author DOI 10.18632/aging.103965↗
  11. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/aging.104091↗
  12. Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4+ T cells. Co-author DOI 10.21037/atm.2020.03.53↗
  13. MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation. First author DOI 10.3389/fonc.2019.01499↗
  14. miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression. Co-author PMID 31217868↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaizhi Wang · 10 shared papers, 2019–2024 · strength 1.28
  2. Shixiang Guo · 6 shared papers, 2020–2026 · strength 1.11
  3. Yingfang Fan · 7 shared papers, 2019–2024 · strength 0.98
  4. Jingyang Yin · 2 shared papers, 2022–2026 · strength 0.40
  5. Junfeng Zhang · 3 shared papers, 2020–2024 · strength 0.39
  6. Lei Cai · 2 shared papers, 2022–2026 · strength 0.36
  7. Tian Tao · 3 shared papers, 2019–2022 · strength 0.36
  8. Fuming Xie · 2 shared papers, 2022–2024 · strength 0.33
  9. Wenjie Huang · 3 shared papers, 2019–2020 · strength 0.32
  10. Songsong Liu · 3 shared papers, 2019–2020 · strength 0.29
  11. Junfeng Zhang · 2 shared papers, 2020–2024 · strength 0.29
  12. J.S. Zhang · 1 shared paper, 2026 · strength 0.26
  13. Dong Wei · 1 shared paper, 2026 · strength 0.26
  14. Junfeng Zhang · 1 shared paper, 2026 · strength 0.26
  15. Pijiang Sun · 1 shared paper, 2026 · strength 0.23
  16. Junfeng Zhang · 1 shared paper, 2026 · strength 0.23
  17. Ashok Kumar Saluja · 1 shared paper, 2026 · strength 0.23
  18. Wen Liang Lu · 1 shared paper, 2023 · strength 0.22
  19. Bing Ni · 2 shared papers, 2020 · strength 0.20
  20. Xianxing Wang · 2 shared papers, 2020 · strength 0.20
  21. Jiali Yang · 1 shared paper, 2024 · strength 0.19
  22. Tao Zhang · 1 shared paper, 2024 · strength 0.19
  23. Qing Chen · 1 shared paper, 2024 · strength 0.19
  24. Bojing Chi · 1 shared paper, 2022 · strength 0.14
  25. Jianbo Li · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.